Apollo Capital Launches Campaign to Restore Value at MediPharm Labs
Apollo Technology Capital Corporation (“Apollo Capital”), a significant shareholder of MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ), has launched a campaign to restore value at the company by nominating six highly qualified director candidates to its Board of Directors. The nominees are John Fowler, Alan D. Lewis, David Lontini, Demetrios Mallios, Regan McGee, and Scott Walters.
Key Points of Apollo Capital’s 5-Pillar Plan
- Replace Failed Leadership with Aligned Executives
- Implement Financial Discipline & Strategic Review
- Retain Strategic Assets for Long-Term Shareholder Value
- Unlock International Medical Growth
- Restore Trust Through Transparency and Good Governance
Apollo Capital has expressed concerns over MediPharm Labs’ severe underperformance, strategic missteps, and destruction of shareholder value, which have cost shareholders $1 billion. The company’s cash position was reduced to $8 million as of March 31, 2025, and is on pace to reach zero by November 2025. Despite these losses, the management team received exorbitant compensation packages, indicating a misalignment with shareholders’ best interests.
The campaign website, www.CureMediPharm.com, details Apollo Capital’s 5-Pillar Plan and the actions the nominees would take in their first 100 days on the Board. Shareholders are urged to disregard MediPharm’s green proxy card and vote the gold proxy card “FOR” Apollo Capital’s six director nominees.
Apollo Capital believes a wholesale Board change is necessary to restore value and accountability at MediPharm Labs. The nominees bring significant turnaround, M&A, and operational expertise to address the company’s current challenges.
For more information and to access Apollo Capital’s Circular and related proxy materials, shareholders can visit SEDAR+ at www.sedarplus.ca or contact Carson Proxy Advisors Ltd. at 1-800-530-5189.
Conclusion
Apollo Capital’s campaign aims to restore value and trust at MediPharm Labs through a comprehensive 5-Pillar Plan and the appointment of experienced director nominees. Shareholders are encouraged to support this initiative by voting for Apollo Capital’s nominees.
